Showing results (111-120 of 552) with videos related to

Sort By:
Pageof 56
Clinical Endocrinology|March 5, 2002
Fracture risk is increased in patients with GH deficiency or untreated prolactinomas--a case-control studyPeter Vestergaard, Jens Otto L Jørgensen, Claus Hagen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 21, 2011
The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled studyTanja Sikjaer, Lars Rejnmark, Lars Rolighed, et al.
Handbook of Experimental Pharmacology|January 1, 2020
Drugs Causing Bone LossPeter Vestergaard
Current Drug Safety|August 12, 2008
Skeletal effects of systemic and topical corticosteroidsPeter Vestergaard
Current Drug Safety|August 12, 2008
Pain-relief medication and risk of fracturesPeter Vestergaard
Expert Review of Neurotherapeutics|December 24, 2008
Fracture risks of antidepressantsPeter Vestergaard
Calcified Tissue International|June 29, 2011
Risk of newly diagnosed type 2 diabetes is reduced in users of alendronatePeter Vestergaard
Current Opinion in Endocrinology, Diabetes, and Obesity|March 21, 2009
Bone metabolism in type 2 diabetes and role of thiazolidinedionesPeter Vestergaard
Calcified Tissue International|December 18, 2014
Effects of adding chymosin to milk on calcium homeostasis: a randomized, double-blind, cross-over studyUlla Kristine Møller, Lars Thorbjørn Jensen, Leif Mosekilde, et al.
Pageof 56